Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03097250 · ClinicalTrials.gov registry record
MRI Spectroscopy and Neuropsychological Functioning in Phenylketonuria
A clinical trial, sponsored by Boston Children's Hospital.
- Completed
- Registry status
- 10
- Enrollment target
NCT03097250: Completed study, sponsored by Boston Children's Hospital.
NCT03097250 is a clinical trial that has completed, run by Boston Children's Hospital. The registered enrollment target is 10 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03097250 has completed, sponsored by Boston Children's Hospital.
- COMPLETED
- Registry status
- 10 participants
- Enrollment target
Study Summary
This is a study about the relationship of brain biomarkers with neuropsychological functioning in PKU. All participants will undergo MRI spectroscopy, will provide a blood specimen and will receive neuropsychological testing.
Primary Outcome
NIH Toolbox Cognitive Battery
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2017-10-25 |
| Est. Completion | 2018-07-01 |
What the finished NCT03097250 record still lists
NCT03097250 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 10 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT03097250 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03097250 about?
NCT03097250 is a clinical study titled "MRI Spectroscopy and Neuropsychological Functioning in Phenylketonuria". This is a study about the relationship of brain biomarkers with neuropsychological functioning in PKU. All participants will undergo MRI spectroscopy, will provide a blood specimen and will receive neuropsychological testing.
What is the current status of trial NCT03097250?
This trial is currently completed. The enrollment target is 10 participants. The study started on 2017-10-25. Estimated completion is 2018-07-01.
Who is sponsoring clinical trial NCT03097250?
This trial is sponsored by Boston Children's Hospital, which has 462 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00623389 · 10 participants · NA
Evaluation of an Advanced Lower Extremity Neuroprostheses
- NCT01241864 · 10 participants · Phase 2
Islet Transplantation in Type 1 Diabetic Kidney Allograft
- NCT01293214 · 10 participants · NA
Vascularized Composite Allotransplantation for Multiple Extremity Amputations
- NCT01474148 · 10 participants · NA
A Neuroprosthesis for Seated Posture and Balance
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI